These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21559023)

  • 1. Clinical trials in cancer.
    Green JA
    Br J Cancer; 2011 May; 104(10):1521-2. PubMed ID: 21559023
    [No Abstract]   [Full Text] [Related]  

  • 2. Interim analyses in clinical trials: why do we plan them?
    Fossâ SD; Skovlund E
    J Clin Oncol; 2000 Dec; 18(24):4007-8. PubMed ID: 11118460
    [No Abstract]   [Full Text] [Related]  

  • 3. Surrogate End Points and Their Validation in Oncology Clinical Trials.
    Zhao F
    J Clin Oncol; 2016 May; 34(13):1436-7. PubMed ID: 26951314
    [No Abstract]   [Full Text] [Related]  

  • 4. Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations.
    Hurria A; Dale W; Mooney M; Rowland JH; Ballman KV; Cohen HJ; Muss HB; Schilsky RL; Ferrell B; Extermann M; Schmader KE; Mohile SG;
    J Clin Oncol; 2014 Aug; 32(24):2587-94. PubMed ID: 25071116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maribavir and human cytomegalovirus-what happened in the clinical trials and why might the drug have failed?
    Marty FM; Boeckh M
    Curr Opin Virol; 2011 Dec; 1(6):555-62. PubMed ID: 22440913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer: dropping bars or rising hoops--phase III outcomes of NSCLC.
    Loong HH; Mok TS
    Nat Rev Clin Oncol; 2014 Jul; 11(7):381-2. PubMed ID: 24840075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. End points in anal cancer: hopes for a common language.
    Glynne-Jones R; Adams RA; Jitlal M; Meadows H
    J Clin Oncol; 2014 Apr; 32(12):1281-2. PubMed ID: 24638005
    [No Abstract]   [Full Text] [Related]  

  • 8. Controversy trails adaptive clinical trials.
    Goozner M
    J Natl Cancer Inst; 2012 Sep; 104(18):1347-8. PubMed ID: 22984199
    [No Abstract]   [Full Text] [Related]  

  • 9. The Children's Oncology Group routinely applies "lack of efficacy" interim monitoring to its randomized clinical trials.
    Anderson JR; Krailo M
    Am J Bioeth; 2011 Mar; 11(3):18-9. PubMed ID: 21400379
    [No Abstract]   [Full Text] [Related]  

  • 10. Innovation in oncology clinical trial design.
    Verweij J; Hendriks HR; Zwierzina H;
    Cancer Treat Rev; 2019 Mar; 74():15-20. PubMed ID: 30665053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials.
    Farrington P; Miller E
    Methods Mol Med; 2003; 87():335-52. PubMed ID: 12958466
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interim analyses].
    Kramar A; Paoletti X
    Bull Cancer; 2007 Nov; 94(11):965-74. PubMed ID: 18055314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific keynote: clinical trial design problems in ovarian cancer.
    Stevenson A; Gore M
    Gynecol Oncol; 2003 Jan; 88(1 Pt 2):S117-21; discussion S122-3. PubMed ID: 12586100
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phases 0, 1 and 2 oncology clinical trials: current questions].
    Penel N; Fournier C; Stéphanie C
    Bull Cancer; 2010 Jan; 97(1):55-63. PubMed ID: 20080458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing risk and improving efficacy of clinical trials: the adaptive design.
    Dangi-Garimella S
    Am J Manag Care; 2014 Aug; 20(11 Spec No.):E8. PubMed ID: 25618150
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized phase II trials: misleading and unreliable.
    Stewart DJ
    J Clin Oncol; 2010 Nov; 28(31):e649-50; author reply e651-3. PubMed ID: 20855829
    [No Abstract]   [Full Text] [Related]  

  • 17. Data monitoring committees for Southwest Oncology Group clinical trials.
    Green S; Crowley J
    Stat Med; 1993 Mar; 12(5-6):451-5. PubMed ID: 8493423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raising the bar for cancer therapy models.
    Francia G; Kerbel RS
    Nat Biotechnol; 2010 Jun; 28(6):561-2. PubMed ID: 20531333
    [No Abstract]   [Full Text] [Related]  

  • 19. Building a Fit for Purpose Clinical Trials Infrastructure to Accelerate the Assessment of Novel Hematopoietic Cell Transplantation Strategies and Cellular Immunotherapies.
    Devine SM; Horowitz MM
    J Clin Oncol; 2021 Feb; 39(5):534-544. PubMed ID: 33434065
    [No Abstract]   [Full Text] [Related]  

  • 20. Avastin saga reveals debate over clinical trial endpoints.
    Sharma SP
    J Natl Cancer Inst; 2012 Jun; 104(11):800-1. PubMed ID: 22673590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.